Navigation Links
Chronic Pain Sufferers Report Relief: DRJ Group Teams With Adult Foster Care Facilities to Evaluate Effectiveness of Stopain Topical Analgesic
Date:4/7/2009

ENCINITAS, Calif., April 7 /PRNewswire/ -- DRJ Group Inc., the makers of all-natural Stopain(R) topical analgesics, today announced the results of an informal study conducted with chronic pain sufferers at two adult foster care facilities.

The test was conducted with residents living at two facilities owned by Leon and Paulette Hanson in Cannon Falls, Minn. The Hansons approached the DRJ Group about conducting an informal study after receiving a complimentary sample of Stopain.

"I was skeptical, but after our test I am convinced that this product works," said Leon Hanson. "I would recommend it--in fact, I have recommended it to others. I am so glad we found Stopain."

"Our business philosophy is to focus on customer feedback when it comes to managing pain," said Bob Miller, president and CEO of DRJ Group, Inc. "When Leon mentioned his residents and their ongoing struggle to manage pain, we were happy to provide Stopain and are very pleased with the results."

Residents began using Stopain in October 2008. Here are Hanson's accounts of two of his residents' experiences with Stopain:

Resident #1: One resident who tried Stopain was a woman in her 90s with shoulder pain that developed after years of manual farm labor. According to Hanson, she had tried a series of pain medications, heat wraps and ointments with no significant relief. When staff at the facility began applying Stopain to her shoulder before her daily nap, she noticed the cooling effect immediately. Hanson says by using Stopain, she was able to sustain relief without needing pain pills.

Resident #2: Another resident who reported relief from Stopain was an 89-year-old woman. Hanson says she developed severe, persistent shoulder pain following a stroke. According to doctors, the shoulder pain did not come from the stroke; the cause of the pain is unknown. After three or four applications of Stopain, she reported significant relief. Hanson explained that the woman used to wince in pain whenever staff lifted her, but the pain subsided after using Stopain.

The active ingredient in Stopain is menthol, recognized by the Food and Drug Administration as an analgesic that provides temporary relief for minor pains and stiffness of arthritis, muscle aches, strains and simple backaches. Stopain products include the top-selling spray and roll-on in the topical analgesics category.

For more information visit www.stopain.com.


'/>"/>
SOURCE DRJ Group Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New research shows how chronic stress worsens neurodegenerative disease course
2. Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease
3. Study identifies key player in the bodys immune response to chronic stress
4. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
5. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
6. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
7. Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007
8. Methadone and systematic follow-up: the best solution for managing chronic pain
9. NASN Joins Partnership to Fight Chronic Disease
10. Stomach Virus a Culprit in Chronic Fatigue Syndrome
11. Chronic fatigue syndrome linked to stomach virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today it ... at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical strategy, ... health analytics to improve Medicaid population health management. , ODH will also have an ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert standing desk ... and advantages built into the home office sit stand solution are bold colors, ... to gain the benefits embedded in the TaskMate Go are available 24/7 through ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of ... of Pittsburgh points to eight genes that may explain why susceptibility to one of ... results of a study published today in the journal npj Schizophrenia. , “There ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Feb. 27, 2017  A landmark study ... , MBBS, PhD, FRACS, of  Sydney Heart and ... Sydney will be published in the February 28, ... American College of Cardiology . According to the study, which ... bypass surgery technique (anOPCABG) reduced postoperative stroke ...
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
Breaking Medicine Technology: